ViaCyte: Clinical Trials

3 trials sponsored by ViaCyte, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Terminated 2, Completed 1
Phase 23Terminated 2, Completed 1

Follow ViaCyte: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus
VC-01 Combination Product - Type 1 Diabetes
Phase 1 / Phase 2TerminatedViaCyte312019-06-252023-10-18
A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness
VC-02 Combination Product - Type 1 Diabetes Mellitus With Hypoglycemia
Phase 1 / Phase 2CompletedViaCyte492017-07-062024-12-03
A Safety, Tolerability, and Efficacy Study of VC-01™ Combination Product in Subjects With Type I Diabetes Mellitus
VC-01™ Combination Product - Type 1 Diabetes Mellitus
Phase 1 / Phase 2TerminatedViaCyte192014-09-012022-03-24

Conditions studied

Diabetes Mellitus, Type 1 (2)

Countries

United States (3)  ·  Canada (2)  ·  Belgium (1)

Top investigators

Gautham Marigowda (1)  ·  Manasi Jaiman, MD (1)

Results publications

PMID 29317381, PMID 29420708, PMID 34193595, PMID 34861146, PMID 35028608, PMID 38012450